Public Market Listing
GRFBME
Live quotes, historical charts, and market capitalization for Grifols are available on Yahoo Finance.
View quote & market cap on Yahoo Finance ↗External market data link · No third-party exchange redistribution
Assets
(3 total)
3Total Assets
1Approved
1Phase 3 / Filed
1Phase 1–2 / Early
2Diseases
Quick filter:
| Target & Modality | |||
|---|---|---|---|
fostamatinib(Tavalisse) | Approved | Spleen tyrosine kinase (Syk)Small molecule | Immune Thrombocytopenia |
| Phase 3 | Hepatitis B virus (HBV)Protein / enzyme therapeutic | Indication not yet linked | |
ABvac40No recent activity | Phase 2 | Amyloid-beta (Aβx-40)Vaccine | Alzheimer's Disease |
Discontinued programmes (1)
Development of these assets stopped. Each page states the sourced discontinuation and keeps the trials as evidence history.
Upcoming events
No upcoming trial completions or earnings dates on record for this company's assets.